Read by QxMD icon Read

The year in cardiology

A Idri, H Benhar, J L Fernández-Alemán, I Kadi
BACKGROUND AND OBJECTIVE: Datamining (DM) has, over the last decade, received increased attention in the medical domain and has been widely used to analyze medical datasets in order to extract useful knowledge and previously unknown patterns. However, historical medical data can often comprise inconsistent, noisy, imbalanced, missing and high dimensional data. These challenges lead to a serious bias in predictive modeling and reduce the performance of DM techniques. Data preprocessing is, therefore, an essential step in knowledge discovery as regards improving the quality of data and making it appropriate and suitable for DM techniques...
August 2018: Computer Methods and Programs in Biomedicine
Antonio F Corno, Paul Smith, Laurynas Bezuska, Branko Mimic
Introduction: We reviewed our experience with decellularized porcine small intestine sub-mucosa (DPSIS) patch, recently introduced for congenital heart defects. Materials and Methods: Between 10/2011 and 04/2016 a DPSIS patch was used in 51 patients, median age 1.1 months (5 days to 14.5 years), for aortic arch reconstruction (45/51 = 88.2%) or aortic coarctation repair (6/51 = 11.8%). All medical records were retrospectively reviewed, with primary endpoints interventional procedure (balloon dilatation) or surgery (DPSIS patch replacement) due to patch-related complications...
2018: Frontiers in Pediatrics
Gulam Muhammed Al Kibria, Krystal Swasey, Allysha Choudhury, Vanessa Burrowes, Kristen A Stafford, S M Iftekhar Uddin, Mohammadhassan Mirbolouk, Atia Sharmeen, Angela Kc, Dipak K Mitra
We analyzed the Bangladesh Demographic and Health Survey 2011 data to examine absolute differences in hypertension prevalence according to the hypertension definition of the "2017 American College of Cardiology/American Heart Association (2017 ACC/AHA) Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults" and "Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7)" 2003 guidelines. Among 7839 participants ≥35 years, the JNC7 and 2017 ACC/AHA classified 25...
June 13, 2018: Journal of Human Hypertension
Michael D Miedema, Zeina A Dardari, Sina Kianoush, Salim S Virani, Joseph Yeboah, Thomas Knickelbine, Veit Sandfort, Carlos J Rodriguez, Khurram Nasir, Michael J Blaha
BACKGROUND: The potential impact of the 2016 United States Preventive Services Task Force (USPSTF) guidelines on statins for primary prevention of atherosclerotic cardiovascular disease (ASCVD) warrants further analysis. METHODS AND RESULTS: We studied participants from MESA (Multi-Ethnic Study of Atherosclerosis) aged 40 to 75 years and not on statins. We compared statin eligibility at baseline (2000-2002) and over follow-up between USPSTF and the 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines...
June 13, 2018: Journal of the American Heart Association
Angela Lowenstern, Shuang Li, Ann Marie Navar, Salim Virani, L Veronica Lee, Michael J Louie, Eric D Peterson, Tracy Y Wang
BACKGROUND: The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol guideline recommends statin treatment based on patients' predicted atherosclerotic cardiovascular disease (ASCVD) risk. Whether clinician-reported guideline adoption translates to implementation into practice is unknown. OBJECTIVES: We aimed to compare clinician lipid management in hypothetical scenarios versus observed practice. METHODS: The PALM Registry asked 774 clinicians how they would treat 4 hypothetical scenarios of primary prevention patients with: (1) diabetes; (2) high 10-year ASCVD risk (≥7...
June 2018: American Heart Journal
Luiz Fernando Ybarra, Marcelo J C Cantarelli, Viviana M G Lemke, Alexandre Schaan de Quadros
Percutaneous coronary intervention in chronic total occlusion is a rapidly evolving area, being considered the last frontier of interventional cardiology. In recent years, the development of new techniques and equipment, as well as the training of specialized personnel, increased their success rates, making it the most predictable procedure available. Although the number of randomized and controlled studies is still limited, results from large multicentered registries allow us to safely offer this intervention to patients, as another treatment option along with the optimized drug treatment and myocardial revascularization surgery...
May 2018: Arquivos Brasileiros de Cardiologia
Jonathan Bates, Craig S Parzynski, Sanket S Dhruva, Andreas Coppi, Richard Kuntz, Shu-Xia Li, Danica Marinac-Dabic, Frederick A Masoudi, Richard E Shaw, Frederick Warner, Harlan M Krumholz, Joseph S Ross
PURPOSE: To estimate medical device utilization needed to detect safety differences among implantable cardioverter defibrillators (ICDs) generator models and compare these estimates to utilization in practice. METHODS: We conducted repeated sample size estimates to calculate the medical device utilization needed, systematically varying device-specific safety event rate ratios and significance levels while maintaining 80% power, testing 3 average adverse event rates (3...
June 12, 2018: Pharmacoepidemiology and Drug Safety
Ajar Kochar, Zhuokai Li, J Kevin Harrison, G Chad Hughes, Vinod H Thourani, Michael J Mack, Roland A Matsouaka, David J Cohen, Eric D Peterson, W Schuyler Jones, Sreekanth Vemulapalli
BACKGROUND: Stroke is a serious complication of both transcatheter aortic valve replacement (TAVR) and carotid artery disease (CD). The implications of CD in patients undergoing TAVR are unclear. METHODS AND RESULTS: The Society of Thoracic Surgeons and American College of Cardiology Transcatheter Valve Therapies Registry, consisting of data from consecutive US TAVR cases during the years 2013 to 2015, was linked to Medicare claims data to ascertain 30-day and 1-year cumulative incidence rates of stroke and all-cause mortality...
June 2018: Circulation. Cardiovascular Interventions
Manolis S Kallistratos, Leonidas E Poulimenos, Sofia Giannitsi, Pavlos Tsinivizov, Athanasios J Manolis
Trimetazidine (TMZ) is a metabolic agent with significant anti-ischemic properties. By inhibiting the terminal enzyme in the β-oxidation pathway, it shifts the energy substrate metabolism, enhancing glucose metabolism. Thus, it maintains the required energy production with less oxygen consumption, an effect necessary in cases of myocardi. Trimetazidine was recently reaccredited as add-on therapy for symptomatic treatment in patients with stable angina, not adequately controlled or intolerant to first-line therapy...
January 1, 2018: Angiology
David Vivas, Inmaculada Roldán, Raquel Ferrandis, Francisco Marín, Vanessa Roldán, Antonio Tello-Montoliu, Juan Miguel Ruiz-Nodar, Juan José Gómez-Doblas, Alfonso Martín, Juan Vicente Llau, María José Ramos-Gallo, Rafael Muñoz, Juan Ignacio Arcelus, Francisco Leyva, Fernando Alberca, Raquel Oliva, Ana María Gómez, Carmen Montero, Fuat Arikan, Luis Ley, Enrique Santos-Bueso, Elena Figuero, Antonio Bujaldón, José Urbano, Rafael Otero, Juan Francisco Hermida, Isabel Egocheaga, José Luis Llisterri, José María Lobos, Ainhoa Serrano, Olga Madridano, José Luis Ferreiro
During the last few years, the number of patients receiving anticoagulant and antiplatelet therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can be expected to need some kind of surgery or intervention during their lifetime that may require treatment discontinuation. The decision to withdraw antithrombotic therapy depends on the patient's thrombotic risk versus hemorrhagic risk. Assessment of both factors will show the precise management of anticoagulant and antiplatelet therapy in these scenarios...
June 7, 2018: Revista Española de Cardiología
Anna Frey, Roxane Sell, György A Homola, Carolin Malsch, Peter Kraft, Ignaz Gunreben, Caroline Morbach, Bálint Alkonyi, Eric Schmid, Isabella Colonna, Edith Hofer, Wolfgang Müllges, Georg Ertl, Peter Heuschmann, László Solymosi, Reinhold Schmidt, Stefan Störk, Guido Stoll
OBJECTIVES: This study sought to determine the spectrum of brain lesions seen in heart failure (HF) patients and the extent to which lesion type contributes to cognitive impairment. BACKGROUND: Cognitive deficits have been reported in patients with HF. METHODS: A total of 148 systolic and diastolic HF patients (mean age 64 ± 11 years; 16% female; mean left ventricular ejection fraction 43 ± 8%) were extensively evaluated within 2 days by cardiological, neurological, and neuropsychological testing and brain magnetic resonance imaging (MRI)...
May 31, 2018: JACC. Heart Failure
Maria Wanitschek, Michael Edlinger, Jakob Dörler, Hannes F Alber
PURPOSE: The Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort is aimed to gain a better understanding of cardiovascular risk factors and their relation to the diagnosis and severity of coronary artery disease, as well as to the long-term prognosis in consecutive (including revascularised) patients referred for elective coronary angiography. PARTICIPANTS: The included patients visited the University Clinic of Cardiology at Innsbruck (Austria), which fulfils a secondary and tertiary hospital function...
June 6, 2018: BMJ Open
Meiwei Zhang, Yeling Wang, Dongmei Chen, Hang Li, Zhiguo Zhang
RATIONALE: Dual atrioventricular nodal non-reentrant tachycardia (DAVNNT) is an uncommon arrhythmia. Because of the different refractory periods of fast and slow pathways, a single atrial depolarization gives rise to 2 ventricular activationsthrough fast and slow pathways separately. PATIENT CONCERNS: A 45-year-old woman was referred to our Cardiology Center with symptoms of recurrent palpitations and fatigue persisting for the previous 3 years. On echocardiography, the ejection fraction of the left ventricle was 45%...
June 2018: Medicine (Baltimore)
Georges Rosario Christian Millogo, Ragomzingba Frank Edgard Zongo, Anita Benao, Estelle Noëla Hoho Youl, Blaise Alexandre Bazona Bassoleth, Moussa Ouédraogo, Patrice Zabsonré, Innocent Pierre Guissou
Medicinal treatment of arterial hypertension (AH) may cause adverse effects which can be annoying and thus influence patient's compliance with treatment. Our study focused on these undesirable effects in patients followed up for AH on an ambulatory basis in the Department of Cardiology at the University Hospital Yalgado Ouédraogo from July to September 2015. Our aim was to determine their rates and their characteristics. Data were obtained from patients' interview, from the examination of patients' follow-up records and of medical consultation forms...
2018: Pan African Medical Journal
Asmâa Biaz, Mohammed Drissi, Aissam El Maataoui, Samira El Machtani Idrissi, Sanae Bouhsain, Abdellah Dami, Abdellatif Boulahya, Zohra Ouzzif
Introduction: This prospective study was conducted at the Laboratoy of Biochemistry of the HMIMV, Rabat, over a period of 1 year. It aimed to analyse the kinetics of troponin lc (cTnl) after on-pump cardiac surgery in order to establish threshold values for the diagnosis of perioperative myocardial infarction. Methods: The study included 58 patients who had undergone on-pump valvular surgery or on-pump coronary artery bypass surgery. These patients were separated into 3 groups according to their clinical and electrical evolution as well as their laboratory tests (cTnI) during the immediate post-operative period...
2018: Pan African Medical Journal
Alain Lekoubou, Kinfe G Bishu, Bruce Ovbiagele
BACKGROUND: In this study, we aimed at estimating the prevalence and number of stroke survivors with hypertension, recommended pharmacological treatment, and above blood pressure target, according to the 2017 American College of Cardiology/American Heart Association guidelines and the seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines. METHODS AND RESULTS: We included participants aged ≥20 years to the National Health and Nutrition Examination Surveys between 2003 and 2014...
June 6, 2018: Journal of the American Heart Association
Kornelia Kotseva, David Wood, Dirk De Bacquer
Aim The purpose of this study was to describe the proportions of patients referred to and attending cardiac rehabilitation programmes in Europe and to compare lifestyle and risk factor targets achieved according to participation in a cardiac rehabilitation programme. Methods The EUROASPIRE IV cross-sectional survey was undertaken in 78 centres from 24 European countries. Consecutive patients aged <80 years with acute coronary syndromes and/or revascularization procedures were interviewed at least six months after their event...
January 1, 2018: European Journal of Preventive Cardiology
Alejandro Cuesta, Carina Guigou, Analía Varela, Lorena Ferrero, María Clara Charlin, Ricardo Lluberas
INTRODUCTION: The consumption of yerba mate (YM) (Ilex paraguariensis) is common in South America and is now used all over the world. It contains many bioactive substances that can be beneficial. There is also the opinion that it may have harmful effects on heart rhythm, but no studies have been found on this. OBJECTIVE: The aim of this study was to evaluate the acute effect of YM on heart rhythm in patients referred for a Holter study. METHOD: A before and after pseudo-experimental clinical study was conducted by performing a Holter on 50 habitual users of YM, and another one after 24 without YM consumption...
June 2, 2018: Archivos de Cardiología de México
José M Di Diego, Charles Antzelevitch
The J wave syndromes, including the Brugada (BrS) and early repolarization (ERS) syndromes, are characterized by the manifestation of prominent J waves in the electrocardiogram appearing as an ST segment elevation and the development of life-threatening cardiac arrhythmias. BrS and ERS differ with respect to the magnitude and lead location of abnormal J waves and are thought to represent a continuous spectrum of phenotypic expression termed J wave syndromes (JWS). Despite over 25 years of intensive research, risk stratification and the approach to therapy of these two inherited cardiac arrhythmia syndromes are still rapidly evolving...
June 5, 2018: Pacing and Clinical Electrophysiology: PACE
M Langouo, I Chouchane, J Lalmand, M Joris, P Dubois
The false aneurysm of the left ventricle is a rare complication after a mitral valvular surgery. It results from the rupture of the ventricular wall inside an adhering pericardium, thus constituting a cavity whose wall is devoid of myocardial elements and communicates with the ventricle by a large collar. Its clinical presentation remains not very specific with an insidious spontaneous evolution which is generally done towards rupture with sudden death by tamponade. Various sophisticated modern diagnostic techniques allows a precise diagnosis...
May 31, 2018: Revue Médicale de Bruxelles
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"